Health and Healthcare
Biophama Firms Lexicon And Poniard In The Hurt Locker
Published:
Last Updated:
Biophama companies are horrible investments at least 90% of the time because they are gambles on the IQs of small groups of scientists and the whims of the FDA. Poniard Pharmaceuticals (PARD) and Lexicon Pharmaceuticals (LXRX) proved the point today by each dropping 10% on heavy volume.
Lexicon Pharmaceuticals told investors how well things were going for the company on February 23. The firm bragged about its advances in treatments for type 2 diabetes, rheumatoid arthritis, and carcinoid syndrome. It was a good day for Lexicon investors. Then, today the firm said it would sell $95 million worth of stock without announcing the offering price. As might be anticipated, the shares were pounded. Lexicon trades at $1.62 today, down from a 52-week high of $3.78, so some fortunate investors have lost half of their money.
Poniard Pharmaceuticals had terrible earnings and indicated that the company should have enough money to make it until the end of this year. It is not clear what will happen then. Maybe Poniard will close. The firm works on treatments for prostate and colorectal cancer. In the fourth quarter of last year, Poniard lost $13.2 million and had no revenue. For the entire year, the loss was $46.2 million. Poniard had $46 million in cash on December 31. The company’s situation is not hopeless, but investors fled the stock pushing it down to $1.62 from a 52-week high of $9.14, so some shareholders have lost 80% of their money over the last year.
The two companies have burned investors badly enough so that it will be nearly impossible for them to recovery any market confidence.
Douglas A. McIntyre
Is Your Money Earning the Best Possible Rate? (Sponsor)
Let’s face it: If your money is just sitting in a checking account, you’re losing value every single day. With most checking accounts offering little to no interest, the cash you worked so hard to save is gradually being eroded by inflation.
However, by moving that money into a high-yield savings account, you can put your cash to work, growing steadily with little to no effort on your part. In just a few clicks, you can set up a high-yield savings account and start earning interest immediately.
There are plenty of reputable banks and online platforms that offer competitive rates, and many of them come with zero fees and no minimum balance requirements. Click here to see if you’re earning the best possible rate on your money!
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
